Director/PDMR/PCA Shareholding

By

Regulatory News | 17 Jun, 2019

Updated : 16:14

RNS Number : 5200C
Biome Technologies PLC
17 June 2019
 

 

 

 

17 June 2019

                   

Biome Technologies plc

("Biome", "the Company" or "the Group")

 

Director/PDMR/PCA Shareholding

                                                                                                        

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, was notified today of the following transactions in the Company's ordinary shares of 5 pence each ("Ordinary Shares").

 

On 17 June 2019, Leapacross Limited (a company controlled by John Standen, Non-Executive Chairman of the Company) sold 28,836 Ordinary Shares at a price of 400p per Ordinary Share. Simultaneously, John Standen purchased 14,418 Ordinary Shares at a price of 400.1p per Ordinary Share into his personal ISA. In addition, and at the same time, John Standen's spouse, Mrs K M Standen, purchased 14,418 Ordinary Shares at a price of 400.1p per Ordinary Share into her personal ISA.

 

As a result of these transactions, the combined beneficial holding of John Standen and Mrs K M Standen remains unchanged at 53,336 Ordinary Shares, which represents approximately 2.26 per cent. of the voting rights over the Company's Ordinary Shares.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them in accordance with the requirements of the EU Market Abuse Regulation can be found below.

 

 

Leapacross Limited

Leapacross Limited is a person closely associated with Biome Technologies plc's Non-Executive Chairman, John Standen, who is a person discharging managerial responsibilities

Price(s)

Volume(s)

400 pence

28,836 ordinary shares

 

17 June 2019

London Stock Exchange (XLON), AIM (BIOM)

 

 

John Standen

Director - Non-Executive Chairman

Price(s)

Volume(s)

400.1 pence

14,418 ordinary shares

 

17 June 2019

London Stock Exchange (XLON), AIM (BIOM)

 

 

Mrs K M Standen

Mrs Standen is a person closely associated with Biome Technologies plc's Non-Executive Chairman, John Standen, who is a person discharging managerial responsibilities

Price(s)

Volume(s)

400.1 pence

14,418 ordinary shares

 

n/a

17 June 2019

London Stock Exchange (XLON), AIM (BIOM)

 

 

-Ends-

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

 

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and that are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited and Stanelco RF Technologies Limited. Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil-based polymers. Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

In 2018, the Board adopted the following three high level KPIs for the next three years to continue its ambitious momentum:

·   Compound revenue growth of 25% per annum across the Group and 40% compound revenue growth in the Bioplastics division

·     Diversify the Group's turnover by product and market to ensure that no one product or end customer contributes more than 15% of revenues by 2020

·   Increase investment in the Group's next generation of products by spending significantly more per annum on average than the £0.3m per annum average spend over the previous strategic objective cycle

 

www.biometechnologiesplc.com

www.biomebioplastics.com and www.thinkbioplastic.com 

www.stanelcorftechnologies.com

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGGUUGQUPBGAM

Last news